Patient Advocates from Greece, Germany, the UK, the Netherlands, Romania and other countries of the WHO European Region exchange thoughts and opinions with TIF about the daunting challenges and concerns the pandemic has brought about for thalassaemia and sickle cell disease patients in these areas.
Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major obtained approval by the EMA
November 7, 2019
June 15, 2020
June 19, 2020
July 22, 2019